What is HC Wainwright’s Estimate for ATNM FY2025 Earnings?
Actinium Pharmaceuticals, Inc. (NYSE:ATNM – Free Report) – HC Wainwright reduced their FY2025 earnings estimates for Actinium Pharmaceuticals in a research note issued on Tuesday, April 1st. HC Wainwright analyst J. Pantginis now expects that the company will earn ($1.30) per share for the year, down from their previous forecast of ($1.04). HC Wainwright has […]
